Rick E Winningham is CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 1.82 Million shares of TBPH, which is worth approximately $15 Million. The most recent transaction as insider was on Nov 20, 2020, when has been sold 13,946 shares (Ordinary Shares) at a price of $17.21 per share, resulting in proceeds of $240,011. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.82M
0.69% 3M change
13.16% 12M change
Total Value Held $15 Million

Rick E Winningham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2020
SELL
Payment of exercise price or tax liability
$240,011 $17.21 p/Share
13,946 Reduced 1.08%
1,275,169 Ordinary Shares

Also insider at

JAZZ
Jazz Pharmaceuticals plc Healthcare
REW

Rick E Winningham

CHIEF EXECUTIVE OFFICER
Dublin 4, L2

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH